INTERWEST PARTNERS X LP's Net Worth

$106 Million

Estimate Recalculated May 22, 2025 08:46PM EST

Who is INTERWEST PARTNERS X LP

INTERWEST PARTNERS X LP has an estimated net worth of $106 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, TESARO, Inc., Doximity, Inc., Invuity, Inc., PMV Pharmaceuticals, Inc., Braze, Inc., Eiger BioPharmaceuticals, Inc., and OBALON THERAPEUTICS INC.

SEC CIK

INTERWEST PARTNERS X LP's CIK is 0001443898

Past Insider Trading and Trends

2020 was INTERWEST PARTNERS X LP's most active year for acquiring shares with 10 total transactions. INTERWEST PARTNERS X LP's most active month to acquire stocks was the month of August. 2021 was INTERWEST PARTNERS X LP's most active year for disposing of shares, totalling 12 transactions. INTERWEST PARTNERS X LP's most active month to dispose stocks was the month of May. 2012 saw INTERWEST PARTNERS X LP paying a total of $5,999,994.00 for 3,071,701 shares, this is the most they've acquired in one year. In 2021 INTERWEST PARTNERS X LP cashed out on 49,224,748 shares for a total of $105,386,872.50, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC

Investor
Updated Nov 25, 2019
Form 4
-100.00%
-2.75M
Nov 25, 2019
Disposition
Nov 21
Form 4
Feb 19, 2019
2.74M
Options
Feb 19
Form 3
Feb 13, 2019
101.61K
Showing 3 results

Doximity, Inc.

Investor
Updated Dec 06, 2021
Form 4
-32.74%
-4.23M
Dec 06, 2021
8.69M
Options
Dec 02
Form 4
-24.67%
-4.23M
Nov 15, 2021
12.92M
Options
Nov 12
Form 4
-20.00%
-4.29M
$24.57
-$105.39M
Jun 28, 2021
17.16M
Sale
Jun 28
Form 3
Jun 23, 2021
Showing 4 results

Invuity, Inc.

Investor
Updated Jun 22, 2015
Form 4
4.78%
49.30K
Jun 22, 2015
1.08M
Options
Jun 18
Form 4
4.78%
49.30K
Jun 22, 2015
1.08M
Options
Jun 18
Form 3
Jun 11, 2015
Form 3
Jun 11, 2015
Showing 4 results

PMV Pharmaceuticals, Inc.

Investor
Updated Jul 14, 2021
Form 4
-9.48%
-471.77K
Jul 14, 2021
4.50M
Disposition
Jul 13
Form 4
-9.11%
-498.55K
May 12, 2021
4.97M
Disposition
May 10
Form 4
-15.41%
-997.11K
Mar 25, 2021
5.47M
Disposition
Mar 24
Form 4/A
0.87%
55.55K
$18.00
Oct 02, 2020
6.47M
Purchase
Sep 25 - Sep 29
Form 4
0.85%
55.00K
$18.00
$990.00K
Sep 29, 2020
6.52M
Purchase
Sep 25 - Sep 29
Form 3
Sep 24, 2020
Showing 6 results

Braze, Inc.

Investor
Updated Feb 09, 2022
Form 4
Feb 09, 2022
3.39M
Options
Feb 08
Form 4
-24.98%
-1.13M
$61.42
-$69.40M
Nov 23, 2021
3.39M
Sale
Nov 19
Form 3
Nov 16, 2021
Showing 3 results

Eiger BioPharmaceuticals, Inc.

Investor
Updated Oct 22, 2018
Form 4
-14.83%
-237.26K
$12.06
-$2.86M
Oct 22, 2018
1.36M
Sale
Oct 18
Form 3
Mar 31, 2016
1.60M
Showing 2 results

OBALON THERAPEUTICS INC

Investor
Updated Aug 08, 2019
Form 4
12.32%
43.75K
$4.00
$100.00K
Aug 08, 2019
398.97K
Purchase
Aug 06
Form 4
44.79%
1.10M
$1.82
$2.00M
Aug 27, 2018
3.55M
Purchase
Aug 23
Form 4
Oct 12, 2016
2.45M
Options
Oct 12
Form 3
Oct 05, 2016
Showing 4 results

TESARO, Inc.

Investor
Updated Aug 07, 2013
Form 4
-19.53%
-600.00K
Aug 07, 2013
2.47M
Disposition
Aug 05
Form 4
-66.60%
-6.12M
$13.50
Jul 05, 2012
3.07M
Buy-Options
Jul 03
Form 3
Jun 27, 2012
Showing 3 results